Root

Kosningar

Forsetakosningar 2024

Dagskrá sjónvarps

Dagskrá útvarps

Auðskilið

Fréttir á auðskildu máli

Ríkisútvarpið

Um RÚV

Íþróttir

Menning og dægurmál

Forsíða

Innlendar fréttir

Erlendar fréttir

Kveikur

Fréttir

Innrás í Úkraínu

Heimskviður

Birgir Þór Harðarson

epa08596835 (FILE) - Journalists wearing protective face masks attend a news conference after ending the first stage of clinical trials of vaccine form against COVID-19, at the Science and Practice Center for Interventional Cardioangiology in Moscow, Russia, 15 July 2020 (reissued 11 August 2020). According to reports, Russian President Putin has announced the registration of a Russian vaccine against the coronavirus SARS-CoV-2 which causes COVID-19.  EPA-EFE/YURI KOCHETKOV

08596835.jpg

epa08596837 (FILE) - (At the table L-R) Elena Smolyarchuk, chief researcher, Head of the Center for Clinical Research on Medications at Sechenov University, and volunteers on whom the Russian vaccine against COVID-19  was tested on, attend a news conference after ending the first stage of clinical trials of vaccine form against COVID-19, at the Science and Practice Center for Interventional Cardioangiology in Moscow, Russia, 15 July 2020 (reissued 11 August 2020). According to reports, Russian President Putin has announced the registration of a Russian vaccine against the coronavirus SARS-CoV-2 which causes COVID-19.  EPA-EFE/YURI KOCHETKOV

08596837.jpg

Rússar skráðu bóluefni gegn COVID-19 í morgun

Heilbrigðismál

Um Ríkisútvarpið

Dreifikerfi RÚV

Mannauður

Persónuvernd

Vefkökustillingar

Framleiðsla og efni

Aðgengi

RÚV English

RÚV Polski

Hlaðvarp

Rás 1

Rás 2

Mitt RÚV

RÚV Orð

Hafa samband

Auglýsingar

Dánarfregnir

Fréttir af RÚV

Stefna og starfsemi

RÚV öpp fyrir snjalltæki

Safn RÚV

Skil á efni til RÚV

About RÚV

RÚV Archive